US patent office to issue decision confirming validity of Pfizer's crystalline patent for Lipitor
Thursday, December 01, 2005 09:00 IST New York
USPTO will confirm the validity of Pfizer's US patent covering the crystalline form of atorvastatin calcium used as the active ingredient in the cholesterol-lowering medicine Lipitor